Uger; Robert Adam
Patent Applications and Registrations
Patent applications and USPTO patent grants for Uger; Robert Adam.The latest application filed is for "treatment of cd47+ disease cells with sirp alpha-fc fusions".
- Uger; Robert Adam - Richmond Hill CA
| Patent | Date |
|---|---|
| Enhancement of CD47 blockade therapy by proteasome inhibitors Grant 11,446,315 - Linderoth , et al. September 20, 2 | 2022-09-20 |
| Treatment Of Cd47+ Disease Cells With Sirp Alpha-fc Fusions App 20210206829 - Uger; Robert Adam ; et al. | 2021-07-08 |
| Improvements In Cd47 Blockade Therapy By Egfr Antibody App 20210040219 - LIN; Gloria Hoi Ying ; et al. | 2021-02-11 |
| Cd47 Blockade Therapy With Cd38 Antibody App 20210040224 - LIN; Gloria Hoi Ying ; et al. | 2021-02-11 |
| Treatment of CD47+ disease cells with SIRP.alpha.-Fc fusions Grant 10,906,954 - Uger , et al. February 2, 2 | 2021-02-02 |
| Cd47 Blockade Therapy App 20200157179 - LIN; Gloria Hoi Ying ; et al. | 2020-05-21 |
| Improvements In Cd47 Blockade Therapy By Hdac Inhibitors App 20190269756 - Linderoth; Emma ; et al. | 2019-09-05 |
| Enhancement Of Cd47 Blockade Therapy By Proteasome Inhibitors App 20190255082 - Linderoth; Emma ; et al. | 2019-08-22 |
| Macrophage Stimulation In Cd47 Blockade Therapy App 20190091290 - Lin; Gloria Hoi Ying ; et al. | 2019-03-28 |
| Treatment of CD47+ Disease Cells with SIRP Alpha-FC Fusions App 20180312563 - Uger; Robert Adam ; et al. | 2018-11-01 |
| Treatment of CD47+ disease cells with SIRP alpha-Fc fusions Grant 9,969,789 - Uger , et al. May 15, 2 | 2018-05-15 |
| Treatment of CD47+ Disease Cells with SIRP Alpha-FC Fusions App 20150329616 - Uger; Robert Adam ; et al. | 2015-11-19 |
| Targeted immunogens App 20040002455 - Uger, Robert Adam ; et al. | 2004-01-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 